Arnold MH. “There is no man living who isn’t capable of doing more than he thinks he can do” … with cognitive enhancement. AJOB Neurosci. 2002;10:54–6.
Article
Google Scholar
Husain M, Mehta MA. Cognitive enhancement by drugs in health and disease. Trends Cogn Sci. 2011;15:28–36.
Article
PubMed
PubMed Central
Google Scholar
Outram SM, Racine E. Examining reports and policies on cognitive enhancement: approaches, rationale, and recommendations. Account Res. 2011;18:323–41.
Article
PubMed
Google Scholar
Partridge BJ, Bell SK, Lucke JC, Yeates S, Hall WD. Smart drugs “as common as coffee”: media hype about neuroenhancement. PLoS ONE. 2011;6:e28416.
Article
PubMed
PubMed Central
Google Scholar
Hall WD, Lucke JC. The enhancement use of neuropharmaceuticals: more scepticism and caution needed. Addiction. 2010;105:2041–3.
Article
PubMed
Google Scholar
de Jongh R, Bolt I, Schermer M, Olivier B. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neurosci Biobehav Rev. 2008;32:760–76.
Article
PubMed
Google Scholar
Schelle KJ, Faulmüller N, Caviola L, Hewstone M. Attitudes toward pharmacological cognitive enhancement—a review. Front Sys Neurosci. 2014;8:53.
Article
Google Scholar
Dijkstra AM, Schuijff M. Public opinions about human enhancement can enhance the expert-only debate: a review study. Public Underst Sci. 2016;25:588–602.
Article
PubMed
Google Scholar
Egan V, Hughes N, Palmer EJ. Moral disengagement, the Dark Triad, and unethical consumer attitudes. Pers Indiv Differ. 2015;76:123–8.
Article
Google Scholar
LeBreton JM, Shiverdecker LK, Grimaldi EM. The Dark Triad and workplace behavior. Annu Rev Organ Psych. 2018;5:387–414.
Article
Google Scholar
Mudrack PE, Bloodgood JM, Turnley WH. Some ethical implications of individual competitiveness. J Bus Ethics. 2012;108:347–59.
Article
Google Scholar
Dresler M, Sandberg A, Ohla K, Bublitz C, Trenado C, Mroczko-Wąsowicz A, Kühn S, Repantis D. Non-pharmacological cognitive enhancement. Neuropharmacology. 2013;64:529–43.
Article
PubMed
Google Scholar
Franke AG, Bagusat C, Rust S, Engel A, Lieb K. Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. Eur Arch Psychiatry Clin. 2014;264:83–90.
Article
Google Scholar
Leon MR, Harms PD, Gilmer DO. PCE use in the workplace: The open secret of performance enhancement. J Manag Inquiry. 2019;28:67–70.
Article
Google Scholar
Smith ME, Farah MJ. Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull. 2011;137:717–41.
Article
PubMed
PubMed Central
Google Scholar
Persson I, Savulescu J. The perils of cognitive enhancement and the urgent imperative to enhance the moral character of humanity. J Appl Philos. 2008;25:162–77.
Article
Google Scholar
Ragan CI, Bard I, Singh I. What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacology. 2013;64:588–95.
Article
PubMed
Google Scholar
Teodorini RD, Rycroft N, Smith-Spark JH. The off-prescription use of modafinil: an online survey of perceived risks and benefits. PLoS ONE. 2020;15:e0227818.
Article
PubMed
PubMed Central
Google Scholar
Repantis D, Schlattmann P, Laisney O, Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res. 2010;62:187–206.
Article
PubMed
Google Scholar
Roberts CA, Jones A, Sumnall H, Gage SH, Montgomery C. How effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphetamine. Eur Neuropsychopharmacol. 2020;38:40–62.
Article
PubMed
Google Scholar
Maier LJ, Ferris JA, Winstock AR. Pharmacological cognitive enhancement among non-ADHD individuals—a cross-sectional study in 15 countries. Int J Drug Policy. 2018;58:104–12.
Article
PubMed
Google Scholar
Dubljević V. Neuroethics, justice and autonomy: public reason in the cognitive enhancement debate, vol. 19. Heidelberg: Springer; 2019.
Book
Google Scholar
Inon M. Fooled by ‘smart drugs’–why shouldn’t pharmacological cognitive enhancement be liberally used in education?. Ethics Educ. 2019;14:54–69.
Article
Google Scholar
Petersen MA, Petersen TS. Why prohibit study drugs? On attitudes and practices concerning prohibition and coercion to use pharmaceutical cognitive enhancement. Drugs (Abingdon Engl). 2019;26:356–64.
Google Scholar
O’Connor C, Joffe H. How the public engages with brain optimization: the media-mind relationship. Sci Technol Hum Values. 2015;40:712–43.
Article
Google Scholar
Fitz NS, Nadler R, Manogaran P, Chong EW, Reiner PB. Public attitudes toward cognitive enhancement. Neuroethics. 2014;7:173–88.
Article
Google Scholar
Kelly D, Morar N. Enhancement, authenticity, and social acceptance in the Age of Individualism. AJOB Neurosci. 2019;10:51–3.
Article
PubMed
Google Scholar
Bergström LS, Lynöe N. Enhancing concentration, mood and memory in healthy individuals: an empirical study of attitudes among general practitioners and the general population. Scand J Public Health. 2008;36:532–7.
Article
PubMed
Google Scholar
Partridge B, Lucke J, Hall W. A comparison of attitudes toward cognitive enhancement and legalized doping in sport in a community sample of Australian adults. AJOB Prim Res. 2012;3:81–6.
Article
Google Scholar
Sattler S, Wörn J. Public perceptions of prescription drug use for cognitive enhancement in healthy children and adolescents. In: Nagel SK, editor. Shaping children. Cham: Springer; 2019. p. 85–103.
Chapter
Google Scholar
Conrad EC, Humphries S, Chatterjee A. Attitudes toward cognitive enhancement: the role of metaphor and context. AJOB Neurosci. 2019;10:35–47.
Article
PubMed
Google Scholar
Mazanov J, Dunn M, Connor J, Fielding ML. Substance use to enhance academic performance among Australian university students. Perform Enhanc Health. 2013;2:110–8.
Article
Google Scholar
Scheske C, Schnall S. The ethics of “smart drugs”: moral judgments about healthy people’s use of cognitive-enhancing drugs. Basic Appl Soc Psych. 2012;34:508–15.
Article
Google Scholar
Petersen MA, Nørgaard LS, Traulsen JM. Going to the doctor with enhancement in mind—an ethnographic study of university students’ use of prescription stimulants and their moral ambivalence. Drugs (Abingdon Engl). 2014;22:201–7.
Google Scholar
Petersen MA, Ølgaard LJLD, Nørgaard LS. Contextualizing study drugs—an exploratory study of perceptions and practices among study counselors, general practitioners, psychiatrists and from student polls. Res Social Adm Pharm. 2019;15:1204–11.
Article
PubMed
Google Scholar
Erasmus N, Kotzé C. Medical students’ attitudes towards pharmacological cognitive enhancement with methylphenidate. Acad Psychiatry. 2020; 1–6.
Sattler S, Forlini C, Racine É, Sauer C. Impact of contextual factors and substance characteristics on perspectives toward cognitive enhancement. PLoS ONE. 2013;8:e71452.
Article
PubMed
PubMed Central
Google Scholar
Sattler S, Sauer C, Mehlkop G, Graeff P. The rationale for consuming cognitive enhancement drugs in university students and teachers. PLoS ONE. 2013;8:e68821.
Article
PubMed
PubMed Central
Google Scholar
Kraus SJ. Attitudes and the prediction of behavior: A meta-analysis of the empirical literature. Pers Soc Psychol Bull. 1995;21:58–75.
Article
Google Scholar
Mayor E, Daehne M, Bianchi R. How perceived substance characteristics affect ethical judgement towards cognitive enhancement. PLoS ONE. 2019;14:e0213619.
Article
PubMed
PubMed Central
Google Scholar
Franke AG, Bonertz C, Christmann M, Engeser S, Lieb K. Attitudes toward cognitive enhancement in users and nonusers of stimulants for cognitive enhancement: a pilot study. AJOB Prim Res. 2012;3:48–57.
Article
Google Scholar
Sabini J, Monterosso J. Judgments of the fairness of using performance enhancing drugs. Ethics Behav. 2005;15:81–94.
Article
PubMed
Google Scholar
Paulhus DL, Williams KM. The Dark Triad of personality: Narcissism, Machiavellianism, and psychopathy. J Res Pers. 2002;36:556–63.
Article
Google Scholar
Semenyna SW, Honey PL. Dominance styles mediate sex differences in Dark Triad traits. Pers Individ Differ. 2015;83:37–43.
Article
Google Scholar
Jonason PK, Slomski S, Partyka J. The Dark Triad at work: how toxic employees get their way. Pers Individ Differ. 2012;52:449–53.
Article
Google Scholar
McDonald MM, Donnellan MD, Navarrete CDA. life history approach to understanding the Dark Triad. Pers Individ Differ. 2012;52:601–5.
Article
Google Scholar
Jonason PK, Webster GD. A protean approach to social influence: Dark Triad personalities and social influence tactics. Pers Individ Differ. 2012;52:521–6.
Article
Google Scholar
Lee K, Ashton MC, Wiltshire J, Bourdage JS, Visser BA, Gallucci A. Sex, power, and money: prediction from the Dark Triad and honesty-humility. Eur J Pers. 2013;27:169–84.
Article
Google Scholar
Campbell WK, Goodie AS, Foster JD. Narcissism, confidence, and risk attitude. J Behav. 2004;17:297–311.
Google Scholar
Djeriouat H, Trémolière B. Shame and guilt situational identification in subclinical primary psychopaths. Curr Psychol. 2020;39:238–45.
Article
Google Scholar
Wastell C, Booth A. Machiavellianism: an alexithymic perspective. J Soc Clin Psychol. 2003;22:730–44.
Article
Google Scholar
Campbell WK, Foster JD, Brunell AB. Running from shame or reveling in pride? Narcissism and the regulation of self-conscious emotions. Psychol Inq. 2004;15:150–3.
Google Scholar
Gramzow R, Tangney JP. Proneness to shame and the narcissistic personality. Pers Soc Psychol Bull. 1992;18:369–76.
Article
Google Scholar
Montebarocci O, Surcinelli P, Baldaro B, Trombini E, Rossi N. Narcissism versus proneness to shame and guilt. Psychol Rep. 2004;94:883–7.
Article
PubMed
Google Scholar
Poless PG, Torstveit L, Lugo RG, Andreassen M, Sütterlin S. Guilt and proneness to shame: unethical behaviour in vulnerable and grandiose narcissism. Eur J Psychol. 2018;14:28–43.
Article
PubMed
PubMed Central
Google Scholar
Di Sarno M, Zimmermann J, Madeddu F, Casini E, Di Pierro R. Shame behind the corner? A daily diary investigation of pathological narcissism. J Res Pers. 2020;85:103924.
Article
Google Scholar
Azizli N, Atkinson BE, Baughman HM, Chin K, Vernon PA, Harris E, Veselka L. Lies and crimes: Dark Triad, misconduct, and high-stakes deception. Pers Individ Differ. 2016;89:34–9.
Article
Google Scholar
Jonason PK, Lyons M, Baughman HM, Vernon PA. What a tangled web we weave: the Dark Triad traits and deception. Pers Individ Differ. 2014;70:117–9.
Article
Google Scholar
Jonason PK, Koenig BL, Tost J. Living a fast life. Hum Nat. 2010;21:428–42.
Article
Google Scholar
Kish-Gephart JJ, Harrison DA, Treviño LK. Bad apples, bad cases, and bad barrels: meta-analytic evidence about sources of unethical decisions at work. J Appl Psychol. 2010;95:1–31.
Article
PubMed
Google Scholar
Jonason PK, O’Connor PJ. Cutting corners at work: an individual differences perspective. Pers Individ Differ. 2017;107:146–53.
Article
Google Scholar
Jonason PK, Slomski S, Partyka J. The Dark Triad at work: how toxic employees get their way. Pers Individ Differ. 2012;52:449–53.
Article
Google Scholar
Nicholls AR, Madigan DJ, Backhouse SH, Levy AR. Personality traits and performance enhancing drugs: the Dark Triad and doping attitudes among competitive athletes. Pers Indiv Differ. 2017;112:113–6.
Article
Google Scholar
Maier LJ, Wunderli MD, Vonmoos M, Römmelt AT, Baumgartner MR, Seifritz E, Schaub MP, Quednow BB. Pharmacological cognitive enhancement in healthy individuals: a compensation for cognitive deficits or a question of personality? PLoS ONE. 2015;10:e0129805.
Article
PubMed
PubMed Central
Google Scholar
Grijalva E, Zhang L. Narcissism and self-insight: a review and meta-analysis of narcissists’ self-enhancement tendencies. Pers Soc Psychol Bull. 2016;42:3–24.
Article
PubMed
Google Scholar
Tracy JL, Robins RW. Putting the self into self-conscious emotions: a theoretical model. Psychol Inq. 2004;15:103–25.
Article
Google Scholar
Balsamo M, Macchia A, Carlucci L, Picconi L, Tommasi M, Gilbert P, Saggino A. Measurement of external shame: an inside view. J Pers Assess. 2015;97:81–9.
Article
PubMed
Google Scholar
Gilbert P, McEwan K, Bellew R, Mills A, Gale C. The dark side of competition: how competitive behaviour and striving to avoid inferiority are linked to depression, anxiety, stress and self-harm. Psychol Psychother. 2009;82:123–36.
Article
PubMed
Google Scholar
Dickerson SS, Gruenewald TL, Kemeny ME. Psychobiological responses to social self threat: functional or detrimental? Self Identity. 2009;8:270–85.
Article
Google Scholar
Kim S, Thibodeau R, Jorgensen RS. Shame, guilt, and depressive symptoms: a meta-analytic review. Psychol Bul. 2011;137:68–96.
Article
Google Scholar
Cheung MP, Gilbert P, Irons C. An exploration of shame, social rank and rumination in relation to depression. Pers Indiv Differ. 2004;36:1143–53.
Article
Google Scholar
Gilbert P, Miles JN. Sensitivity to Social Put-Down: it’s relationship to perceptions of social rank, shame, social anxiety, depression, anger and self-other blame. Pers Indiv Differ. 2000;29:757–74.
Article
Google Scholar
Gilbert P. The evolution of shame as a marker for relationship security: a biopsychosocial approach. In: Tracy JL, Robins RW, Tangney JP, editors. The self-conscious emotions: theory and research. New York: Guilford Press; 2007. p. 283–309.
Google Scholar
Saggino A, Carlucci L, Sergi MR, D’Ambrosio I, Fairfield B, Cera N, Balsamo MA. A validation study of the psychometric properties of the Other as Shamer Scale–2. SAGE Open. 2017;7:2158244017704241.
Article
Google Scholar
Murayama K, Elliot AJ. The competition–performance relation: a meta-analytic review and test of the opposing processes model of competition and performance. Psychol Bull. 2012;138:1035–170.
Article
PubMed
Google Scholar
Smith JR, Hogg MA. Social identity and attitudes. In: Crano W, Prislin R, editors. Attitudes and attitude change. New York: Psychology Press; 2008. p. 337–60.
Google Scholar
Roulin N, Krings F. When winning is everything: the relationship between competitive worldviews and job applicant faking. Appl Psychol. 2016;65:643–70.
Article
Google Scholar
McCabe DL, Treviño LK, Butterfield KD. Cheating in academic institutions: a decade of research. Ethics Behav. 2001;11:219–32.
Article
Google Scholar
Garasic MD, Lavazza A. Moral and social reasons to acknowledge the use of cognitive enhancers in competitive-selective contexts. BMC Med Ethics. 2016;17:18.
Article
PubMed
PubMed Central
Google Scholar
McIlwain D. Young Machiavellians and the traces of shame: coping with vulnerability to a toxic affect. In: Barry CT, Kerig PK, Stellwagen KK, Barry TD, editors. Narcissism and Machiavellianism in youth: implications for the development of adaptive and maladaptive behavior. Washington: American Psychological Association; 2011. p. 213–31.
Chapter
Google Scholar
Buhrmester M, Kwang T, Gosling SD. Amazon’s mechanical turk: a new source of inexpensive, yet high-quality, data? Perspect Psychol Sci. 2011;6:3–5.
Article
PubMed
Google Scholar
Jonason PK, Webster GD. The dirty dozen: a concise measure of the Dark Triad. Psychol Assess. 2010;22:420–32.
Article
PubMed
Google Scholar
Brown SP, Cron WL, Slocum JW. Effects of trait competitiveness and perceived intraorganizational competition on salesperson goal setting and performance. J Mark. 1998;62:88–98.
Article
Google Scholar
Bostrom N, Sandberg A. Cognitive enhancement: methods, ethics, regulatory challenges. Sci Eng Ethics. 2009;15:311–41.
Article
PubMed
Google Scholar
Harrison A, Summers J, Mennecke B. The effects of the dark triad on unethical behavior. J Bus Ethics. 2018;153:53–77.
Article
Google Scholar
Allport GW. Pattern and growth in personality. New York: Holt, Rinehart & Winston, American Psychiatric Association; 1961.
Google Scholar
Kandias M, Mylonas A, Virvilis N, Theoharidou M, Gritzalis D. An insider threat prediction model. In: International conference on trust, privacy and security in digital business. 2010. Springer, Berlin, Heidelberg; 2010. p. 26–37.
Effelsberg D, Solga M, Gurt J. Transformational leadership and follower’s unethical behavior for the benefit of the company: a two-study investigation. J Bus Ethics. 2014;120:81–93.
Article
Google Scholar
Lata M, & Chaudhary R. Workplace spirituality and experienced incivility at work: Modeling Dark Triad as a moderator. J Bus Ethics. 2020; 1–23.
Jonason PK, Wee S, Li NP, Jackson C. Occupational niches and the Dark Triad traits. Pers Indiv Differ. 2014;69:119–23.
Article
Google Scholar
Fehr B, Samsom D, Paulhus DL. The construct of Machiavellianism: twenty years later. In: Spielberger CD, Butcher JN, editors. Advances in personality assessment. Hillsdale: Erlbaum; 1992. p. 77–116.
Google Scholar